sipIT digital support to help people with kidney stones drink more
Efficacy of sipIT Intervention for Increasing Urine Output in Patients with Urolithiasis
This project offers a phone-based sipIT tool to help people with kidney stones drink enough fluid to reach about 2.5 liters of urine per day.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11141318 on NIH RePORTER |
What this research studies
I would use a smartphone app called sipIT that gives timely reminders and support to help me drink fluids during the day. The app was designed with input from people who have had kidney stones and adapts its prompts to my daily routine and context. In the research, participants will use the app while the team tracks urine output and adherence over time to see if the tool helps people meet urine-volume goals. The team has already done several small studies and will enroll more participants to test the approach more broadly.
Who could benefit from this research
Good fit: Adults with a history of kidney stones who are willing to use a smartphone app and follow instructions for tracking fluid intake or urine output are the best fit.
Not a fit: People without a history of kidney stones, those who cannot or will not use a smartphone app, or patients with medical fluid restrictions (for example advanced heart failure or dialysis) may not benefit.
Why it matters
Potential benefit: If successful, sipIT could help people maintain higher urine output and reduce painful, costly recurrences of kidney stones.
How similar studies have performed: Small preliminary studies and other digital reminder programs have shown promise for improving fluid intake, but larger trials are still needed to confirm benefits.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Conroy, David E. — University of Michigan at Ann Arbor
- Study coordinator: Conroy, David E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.